Azvudine/CL-197

N/A

Report date: 2025/04/29 16:09:28
NME

Base Information

Drug NameAzvudine/CL-197
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitorsVirion infectivity factor inhibitorsRNA-directed RNA polymerase inhibitors +[4] 
TargetsHuman immunodeficiency virus type 1 reverse transcriptaseVirion infectivity factorRNA-directed RNA polymerase +[4] 
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AzvudineCL-197
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHenan Genuine Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHenan Genuine Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A